Patents by Inventor Robert Bartlett Elliott

Robert Bartlett Elliott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040213768
    Abstract: Method of preparing and administering a treatment species to a mammalian recipient, the treatment species including one or more of:
    Type: Application
    Filed: January 15, 2004
    Publication date: October 28, 2004
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Christopher Edward Williams
  • Publication number: 20040033216
    Abstract: The invention relates to developments in the treatment of diabetes in mammals.
    Type: Application
    Filed: May 22, 2003
    Publication date: February 19, 2004
    Inventors: Robert Bartlett Elliott, Riccardo Calafiore, Gusseppe Basta
  • Publication number: 20040014212
    Abstract: The invention relates to a method of preparing a xenotransplantable porcine islet preparation capable upon xenotransplantation of producing porcine insulin in an appropriate recipient mammal, the method including or comprising: (i) harvesting the pancreas of piglets at or near full term gestation, and (ii) extracting islets from a culture of the harvested pancreas using a suitable collagenase, (iii) the culture of the harvested pancreas being a) of mechanically reduced harvested pancreas, and b) a supportive mammalian albumin substantially free of non-human microbiological agents,wherein (at least some stage in the method) the islets are associated with Sertoli cells.
    Type: Application
    Filed: June 25, 2003
    Publication date: January 22, 2004
    Inventors: Robert Bartlett Elliott, Guiseppe Basta, Giovanni Luca, Riccardo Calafiore
  • Patent number: 5725860
    Abstract: The incidence of the autoimmune disease, diabetes mellitus, is well controlled in the nude-obese-diabetic (NOD) mouse model using injections of the A chain fragment (or parts thereof) of the insulin molecule as an antigen in combination with killed cells (or parts thereof) of Haemophilus pertussis, acting as an adjuvant. This leads to the convenient prevention of diabetes in humans using the common "Triple vaccine" (DPT) diphtheria/whooping cough/tetanus vaccine (or versions thereof) in combination with A chain fragment of insulin. This mixture can be given to an at-risk population in which diabetes is expected to occur at an abnormally high rate, or it can be given to the entire population.
    Type: Grant
    Filed: August 7, 1996
    Date of Patent: March 10, 1998
    Assignee: Auckland UniServices Limited
    Inventor: Robert Bartlett Elliott